Spironolactone Tablet, Film Coated
Product Images NDC 70518-4512

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70518-4512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 01)
Chemical structure of spironolactone, illustrating its steroidal framework with characteristic lactone and thiolactone groups visible in the diagram.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 02)
A Kaplan-Meier survival curve comparing the probability of an event over time in months for patients treated with spironolactone versus placebo. The graph shows two lines, one for spironolactone (n=822) and one for placebo (n=841), with a log-rank p-value less than 0.001, indicating a statistically significant difference between the groups.*
FDA Label Image

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)

Image (19dcadf3 8242 413a 9a0d A2181ef1e2ff 03)
A forest plot displaying hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups comparing spironolactone versus placebo. Subgroups include age, sex, race, left ventricular ejection fraction, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. The plot visualizes treatment effect direction and strength across these categories with sample sizes (N) and proportions (%) shown.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for spironolactone 100 mg film-coated tablets, 100 tablets per box. The label includes the NDC number 70518-4512-00, manufacturer Zydus Pharmaceuticals, and repackager RemedyRepack Inc. It notes storage instructions, dosage form as round white tablets, and prescription-only status.*
FDA Label Image

Mm2 (Spironolactone 100mg 70518 4512 01)

Mm2 (Spironolactone 100mg 70518 4512 01)
Label for Spironolactone Tablet 100 mg, film-coated, oral dosage form. The package contains 1 tablet. Label shows the NDC 70518-4512-01 and indicates repackaging by RemedyRepack Inc., Indiana, PA. Manufacturer is Zydus Pharm, Pennington, NJ. Storage instructions and warnings to keep out of reach of children are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.